We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 28,826

The pitfalls of settling qui tam lawsuits

  • Ober Kaler
  • -
  • USA
  • -
  • March 27 2015

In a recent federal court case, the federal government and the State of California successfully enforced an oral settlement agreement of a qui tam

Worthless Services investigations and settlements: the enforcement trend continues

  • Ober Kaler
  • -
  • USA
  • -
  • March 27 2015

In recent years, state and federal governments have shown their willingness to criminally pursue skilled nursing home owners and operators for

Inter partes review (IPR): an alternative pathway for biosimilars

  • Baker Botts LLP
  • -
  • USA
  • -
  • March 27 2015

A "biosimilar" is a biological product, e.g., a therapeutic antibody, that is not only highly similar to an existing FDA-approved biological product

Teva Pharmaceuticals: is it time to rethink how you will argue claim construction?

  • Dickinson Wright PLLC
  • -
  • USA
  • -
  • March 27 2015

The United States Supreme Court decided in Teva Pharmaceuticals USA Inc. v. Sandoz Inc. that the Federal Circuit must review all subsidiary factual

King v. Burwell: the Supreme Court hears the case about health insurance subsidies

  • Alston & Bird LLP
  • -
  • USA
  • -
  • March 26 2015

On March 4, 2015, the U.S. Supreme Court heard oral argument in King v Burwell, No. 14-1158, a case challenging the legality of an IRS rule under

Let’s talk inFuse

  • Dechert LLP
  • -
  • USA
  • -
  • March 26 2015

The InFuse litigation has certainly given us quite a lot to talk about and almost all of it positive. It has been a treasure trove for defendants

U.S. Supreme Court clarifies standard for challenging an expression of opinion in registration statement

  • Ropes & Gray LLP
  • -
  • USA
  • -
  • March 26 2015

On March 24, 2015, the U.S. Supreme Court limited a securities plaintiff's ability to claim a remedy for statements of "belief" or "opinion" that

Omnicare decision clarifies grounds for Section 11 liability

  • Morgan Lewis & Bockius LLP
  • -
  • USA
  • -
  • March 26 2015

On March 24, the US Supreme Court issued its highly anticipated decision in Omnicare Inc. v. Laborers District Council Construction Industry Pension

Congressional health policy hearings

  • Reed Smith LLP
  • -
  • USA
  • -
  • March 26 2015

Congressional committees have held several hearings this week on health policy issues. On March 24, the Energy and Commerce Health Subcommittee held

Supreme Court applies “reasonable” standard for statements of opinion under Section 11

  • Freshfields Bruckhaus Deringer LLP
  • -
  • USA
  • -
  • March 26 2015

Yesterday, the United States Supreme Court unanimously decided that public companies and their officers cannot be held liable under Section 11 of the